The Knight ADRC has supported many investigators at Washington University and at other institutions over the years. We wish to avoid the situation where two investigators study the same research question to avoid duplication of effort and potential conflict. To determine if your topic has already been studied with our resources, please search our database. If you find that your topic or a related topic has been submitted, you may wish to contact the investigator to inquire about their findings to determine how you might proceed. You may wish to collaborate or modify your request to avoid overlap. The results below reflect requests made since online requests have been accepted. As such, not all fields will have data as certain information, such as aims, were not collected until recently. If an entry has been assigned an ID number (e.g. T1004), the full request has been submitted and is either approved, disapproved or in process. If an entry has no ID number, then it represents a submission that has not yet been reviewed. Search terms are applied across an entire requests application including variables not displayed below. A more specific, detailed search may yield better results depending upon your needs.
Search Terms:
Investigator: Berislav V. Zlokovic
Project Title: CSF BIOMARKERS OF BLOOD-BRAIN BARRIER BREAKDOWN IN COGNITIVELY NORMAL AND ALZHEIMER’S INDIVIDUALS
Date: December 21, 2021 at 5:02 pm
Request ID: T1234
Aim 1: TO DETERMINE THE EFFECTS OF APOE GENOTYPE ON CSF MARKERS OF BBB BREAKDOWN IN COGNITIVELY NORMAL
Aim 2: TO DETERMINE THE EFFECTS OF APOE GENOTYPE ON CSF MARKERS OF BBB BREAKDOWN IN MILD AND SEVERE AD
Aim 3:
Aim 4:
Investigator: Nikolaos Robakis
Project Title: Correlation of microRNA and protein expression in AD brains
Date: December 21, 2021 at 5:02 pm
Request ID: T1229
Aim 1: Levels of neuronal microRNAs and target proteins, including PEA-15 and EphB2 in AD brains.
Aim 2:
Aim 3:
Aim 4:
Investigator: Berislav V Zlokovic
Project Title: Pericyte deficiency and blood-brain barrier breakdown in various Alzheimer’s disease APOE genotypes
Date: December 21, 2021 at 5:02 pm
Request ID: T1230
Aim 1: To determine the effects of APOE genotype on blood-brain barrier permeability in AD
Aim 2: To determine the effects of APOE genotype on pericyte coverage and number in AD
Aim 3: Investigate cell-specific distribution and levels of LRP-1 and MMP-9 in AD
Aim 4:
Investigator: Alison Goate
Project Title: Defining the mechanisms of AD pathogenesis in human IPSC-derived neurons
Date: December 21, 2021 at 5:02 pm
Request ID: T1301
Aim 1: To measure the influence of pathogenic FAD mutations on APP and tau metabolism in human neurons
Aim 2:
Aim 3:
Aim 4:
Investigator: Philip B. Verghese
Project Title: Amendment to “Apolipoprotein E Isoforms and Aβ Metabolism (T1005)”
Date: December 21, 2021 at 5:02 pm
Request ID: T1005-A
Aim 1: Characterize the CNS apoE isoform-associated proteome and lipidome in normal and AD subjects
Aim 2: Determine how lipids and proteins of apoE isoforms modulate apoE functions
Aim 3:
Aim 4:
Investigator: Langford
Project Title: importance of PINCH protein levels in CSF in AD
Date: December 21, 2021 at 5:02 pm
Request ID: T1323
Aim 1: do levels of PINCH protein in CSF correspond to neurocognitive status in AD
Aim 2: do levels of PINCH protein in CSF correspond to immune system functional status
Aim 3:
Aim 4:
Investigator: Marc I. Diamond
Project Title: Characterizing tau aggregate species via structural mapping
Date: December 21, 2021 at 5:02 pm
Request ID: T1322
Aim 1: Cluster tauopathy patients in clinically meaningful ways via structural mapping of tau aggregates.
Aim 2: Determine if disease progression rates are influenced by tau aggregate protein structure.
Aim 3: Determine if tau aggregate protein structure is consistent between brain regions.
Aim 4:
Investigator: Joel Kramer
Project Title: Disease-free Aging Control Group for Tau Consortium Genetic Studies
Date: December 21, 2021 at 5:02 pm
Request ID: T1321
Aim 1: provide DNA from functionally normal controls without family history of neurodegenerative disease
Aim 2:
Aim 3:
Aim 4:
Investigator: Makoto Ishii
Project Title: Altered leptin signaling in Alzheimer’s disease
Date: December 21, 2021 at 5:02 pm
Request ID: T1318
Aim 1: To determine if alterations in leptin signaling are found in earliest stages of Alzheimer’s disease
Aim 2:
Aim 3:
Aim 4:
Investigator: Sidney Strcikland
Project Title: Identification of a Plasmin-Resistant Fibrin Fragment as a Biomarker for Alzheimer’s disease
Date: December 21, 2021 at 5:02 pm
Request ID: T1320
Aim 1: Determine a level of plasmin-resistant fibrin fragment in CSF from AD patients
Aim 2: The relationship between a level of Fibrin Fragment and pathological characteristics of AD patients
Aim 3:
Aim 4: